- Capital Cube•yesterday
Click here to see latest analysis ETF’s with exposure to Peregrine Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker […]
- Capital Cube•9 days ago
Click here to see latest analysisPeregrine Pharmaceuticals, Inc. reports financial results for the year ended April 30, 2016.HighlightsGross margins widened from 41.78% to 48.61% compared to the same period last year, operating (EBITDA) margins now -122.69% from -184.68%.Change in operating cash flow of -9.92% compared to same period last year is about the same as […] (Read more...) The post Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: 2016 By the Numbers : July 22, 2016 appeared first on CapitalCube.